One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research
Jeremy Basset-Sagarminaga, Tineke van de Weijer, Patricia Iozzo, Patrick Schrauwen & Vera Schrauwen-Hinderling
The impact of taxing sugar-sweetened beverages on diabetes: a critical review
José L. Peñalvo
Type 2 diabetes and succinate: unmasking an age-old molecule
Sonia Fernández-Veledo, Anna Marsal-Beltran & Joan Vendrell
Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review
Rabeeyah Ahmed, Russell J. de Souza, Vincent Li, Laura Banfield & Sonia S. Anand
Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study
Edward W. Gregg, Haiying Chen, Michael P. Bancks, Raoul Manalac, Nisa Maruthur, Medha Munshi & Rena Wing for the Look AHEAD Research Group
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
Matthias Blüher, Julio Rosenstock, Josef Hoefler, Raymond Manuel & Anita M. Hennige
Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study
Arunkumar Krishnan, Carolin V. Schneider, Yousaf Hadi, Diptasree Mukherjee, Bandar AlShehri & Saleh A. Alqahtani
Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study
Peter J. Raubenheimer, Joanna Skelton, Bukiwe Peya, Joel A. Dave & Naomi S. Levitt
MTNR1BÂ genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial
Yoriko Heianza, Tao Zhou, Xuan Wang, Jeremy D. Furtado, Lawrence J. Appel, Frank M. Sacks & Lu Qi
Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018
Nolwenn Regnault, Elodie Lebreton, Luveon Tang, Sandrine Fosse-Edorh, Yaya Barry, Valérie Olié, Cécile Billionnet, Alain Weill, Anne Vambergue & Emmanuel Cosson
GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
Nikhil R. Gandasi, Rui Gao, Lakshmi Kothegala, Abigail Pearce, Cristiano Santos, Samuel Acreman, Davide Basco, Anna Benrick, Margarita V. Chibalina, Anne Clark, Claudia Guida, Matthew Harris, Paul R. V. Johnson, Jakob G. Knudsen, Jinfang Ma, Caroline Miranda, Makoto Shigeto, Andrei I. Tarasov, Ho Yan Yeung, Bernard Thorens, Ingrid W. Asterholm, Quan Zhang, Reshma Ramracheya, Graham Ladds & Patrik Rorsman
NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function
Sharon Baumel-Alterzon, Liora S. Katz, Luca Lambertini, Isabelle Tse, Fatema Heidery, Adolfo Garcia-Ocaña & Donald K. Scott
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy
Roshan Dhanapalaratnam, Tushar Issar, Alexandra T. K. Lee, Ann M. Poynten, Kerry-Lee Milner, Natalie C. G. Kwai & Arun V. Krishnan
Comments on the notion of false positivity in measurements of autoantibodies
Valdemar Grill, Elin Sørgjerd, Ingrid Hals & Sofia Carlsson
Comments on the notion of false positivity in measurements of autoantibodies. Reply to Grill V, Sørgjerd E, Hals I, Carlsson S [letter]
Nicholas J. Thomas & Angus G. Jones
